Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.
Kenji YoshiokaYuya MatsueTetsuo YamaguchiTakeshi KitaiNobuyuki KagiyamaTakahiro OkumuraKeisuke KidaShogo OishiEiichi AkiyamaSatoshi SuzukiMasayoshi YamamotoShunsuke KurodaAkihiko MatsumuraKenzo HiraoPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
Early initiation of ACEIs/ARBs within 48 h of admission for hospitalized patients with AHF was not associated with adverse events and correlated with improved outcomes at 1 year from admission.